Triamterene and Hydrochlorothiazide Tablets recall: Contamination
Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC…
Why was Triamterene and Hydrochlorothiazide Tablets recalled?
Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: GW8264, HD3095, Exp 12/18
- Product
- Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC…
- Recalling firm
- Sandoz Incorporated
- Quantity
- 11,680 bottles
- Distribution
- Nationwide in the USA and Puerto Rico
- Recall date
- April 25, 2018
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)